Defining Structure‐Function Relationships of Amphiphilic Excipients Enables Rational Design of Ultra‐Stable Biopharmaceuticals
Advanced Science · 2025-02 · 12 (8)
DOI: 10.1002/advs.202409604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 07.01.2025. Verfasst von Alexander N Prossnitz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science & Engineering, Stanford University, Stanford, CA, 94305, USA. Hauptthemen laut MEDLINE: Excipients, Surface-Active Agents, Biological Products. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stanford Maternal and Child Health Research Institute postdoctoral fellowship, Stanford Graduate Fellowship in Science and Engineering, National Science Foundation Graduate Research Fellowship.
Abstract (Originalsprache)
Biopharmaceuticals are the fastest‐growing class of drugs in the healthcare industry, but their global reach is severely limited by their propensity for rapid aggregation. Currently, surfactant excipients such as polysorbates and poloxamers are used to prevent protein aggregation, which significantly extends shelf‐life. Unfortunately, these excipients are themselves unstable, oxidizing rapidly into 100s of distinct compounds, some of which cause severe adverse events in patients. Here, the highly stable, well‐defined, and modular nature of amphiphilic polyacrylamide‐derived excipients is leveraged to isolate the key mechanisms responsible for excipient‐mediated protein stabilization. With a library of compositionally identical but structurally distinct amphiphilic excipients, a new property is quantified, compositional dispersity, that is key to excipient performance and utilized this property to rationally design new ultra‐stable surfactant excipients that increase the stability of a notoriously unstable biopharmaceutical, monomeric insulin, by an order of magnitude. This comprehensive and generalizable understanding of excipient structure‐function relationships represents a paradigm shift for the formulation of biopharmaceuticals, moving away from trial‐and‐error screening approaches toward rational design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Materials Science & Engineering, Stanford University, Stanford, CA, 94305, USA.
- Department of Biochemistry, Stanford University, Stanford, CA, 94305, USA.
- Department of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
- Department of Physics, University of Washington, Seattle, WA, 98195, USA.
- Department of Health Technology Cell and Drug Technologies, Technical University of Denmark, Lyngby, 2800, Denmark.
- Department of Pediatrics ̶ Endocrinology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
ORCID-Profile: Eric A Appel
Förderung
- Stanford Maternal and Child Health Research Institute postdoctoral fellowship
- Stanford Graduate Fellowship in Science and Engineering
- National Science Foundation Graduate Research Fellowship
- JDRF
Zitieren
APA
Prossnitz, A. N., Nguyen, L. T., Eckman, N., Borkar, S., Tetef, S., Autzen, A. A. A., Fuller, G. G., & Appel, E. A. (2025). Defining Structure‐Function Relationships of Amphiphilic Excipients Enables Rational Design of Ultra‐Stable Biopharmaceuticals. Advanced Science, 12(8). https://doi.org/10.1002/advs.202409604
Vancouver
Prossnitz AN, Nguyen LT, Eckman N, Borkar S, Tetef S, Autzen AAA, et al. Defining Structure‐Function Relationships of Amphiphilic Excipients Enables Rational Design of Ultra‐Stable Biopharmaceuticals. Advanced Science. 2025;12(8). doi:10.1002/advs.202409604
BibTeX
@article{Prossnitz2025,
author = {Prossnitz, Alexander N and Nguyen, Leslee T and Eckman, Noah and Borkar, Suraj and Tetef, Samantha and Autzen, Anton A A and Fuller, Gerald G and Appel, Eric A},
title = {Defining Structure‐Function Relationships of Amphiphilic Excipients Enables Rational Design of Ultra‐Stable Biopharmaceuticals},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {8},
doi = {10.1002/advs.202409604}
}
EUVIMED